Gemcitabine can trigger apoptosis in pancreatic carcinoma cells by lowering the expression of Bcl-2 and activating caspases; it can also induce reactive oxygen species and block cell cycle in the S phase [33]. The gene discussed is BCL2; the disease is exocrine pancreatic carcinoma.